[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Friday, 19 November, 2004, 22:53 GMT
Bayer drug deal gets green light
Drug brand
The deal brings together many famous medicines
German pharmaceutical firm Bayer's 2.3bn euro (1.6bn) purchase of Roche's over-the-counter drugs unit has been cleared by the European Commission.

The deal will transform Bayer into the world's third-largest supplier of over-the-counter medicines behind Johnson & Johnson and GlaxoSmithKline.

The deal will bring together famous brands such as Alka-Seltzer and Rennie.

To satisfy competition issues, Bayer will have to sell off a number of drugs and trademarks in Austria and Ireland.

The combined business, whose headquarters will be in the United States, will employ 6,700 staff worldwide.

"The clearance is subject to a number of conditions intended to safeguard competition and hence the interests of European consumers," the Commission said in a statement.

The deal is expected to be completed before the end of the year.


SEE ALSO:
Bayer to buy Roche consumer arm
19 Jul 04 |  Business
Bayer profits dip ahead of revamp
11 Nov 03 |  Business
Bayer to spin-off chemicals unit
07 Nov 03 |  Business


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific